Development and validation of a dried blood spot-LC-APCI-MS assay for estimation of canrenone in paediatric samples

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 9-10, 2010, Pages 769-776

  Suyagh, Maysa Faisal ^a   Kole, Prashant Laxman ^a   Millership, Jeff ^a   Collier, Paul ^a   Halliday, Henry ^b   McElnay, James C ^a  

^a Medical Biology Centre   (United Kingdom)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

APCI; Canrenone; Clinical validation; Dried blood spots; Guthrie card; Solid phase extraction

Indexed keywords

ATMOSPHERIC PRESSURE CHEMICAL IONISATION; CALIBRATION CURVES; CHROMATOGRAPHIC SEPARATIONS; DRIED BLOOD SPOTS; GUTHRIE CARD; HIGH ORGANIC; INTERNAL STANDARDS; ISOCRATIC ELUTION; LC-APCI-MS; LOWER LIMIT OF QUANTIFICATIONS; METHANOLIC EXTRACTS; METHANOLIC SOLUTION; METHYL-TESTOSTERONE; MOBILE PHASE; REVERSED-PHASE COLUMNS; SAMPLE COLLECTION; SELECTED-ION MONITORING; SOLID-PHASE EXTRACTION; TARGET IONS; VALIDATED METHODS; WHOLE BLOOD;

ACETONITRILE; ATMOSPHERIC PRESSURE; BLOOD; CHROMATOGRAPHIC ANALYSIS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; METHANOL; PEDIATRICS;

EXTRACTION;

CANRENONE; METHYLTESTOSTERONE;

ACCURACY; ARTICLE; BLOOD STAIN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT; DRUG DETERMINATION; DRUG STRUCTURE; EVAPORATION; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEWBORN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

CANRENONE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY;

EID: 77549085398     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.01.031     Document Type: Article

References (40)

1. van der Vorst M.M., Kist J.E., van der Heijden A.J., and Burggraaf J. Paediatr. Drugs 8 (2006) 245
2. Garthwaite S.M., and McMahon E.G. Mol. Cell. Endocrinol. 217 (2004) 27
3. Parthasarathy H.K., Alhashmi K., McMahon A.D., Struthers A.D., Connell J.M., McInnes G.T., Ford I., and MacDonald T.M. BMC Cardiovasc. Disord. 7 (2007) 14
4. Royal College of Paediatrics and Child Health and Neonatal and Paediatric Pharmacists Group, Medicines for Children, 2nd ed., London, 2003.
5. Krause W., Karras J., and Seifert W. Eur. J. Clin. Pharmacol. 25 (1983) 449
6. Peterfalvi M., Torelli V., Fournex R., Rousseau G., Claire M., Michaud A., and Corvol P. Biochem. Pharmacol. 29 (1980) 353
7. Buck M.L. Ann. Pharmacother. 39 (2005) 823
8. U.S. Department of Health and Human Services. Federal Register 68 (2003) 2789
9. European Medicines Agency (EMEA), Priority List for Studies into Off-Patent Paediatric Medicinal Products, Report Number EMEA/197972/2007, London, 2007.
10. Gochman N., and Gantt C.L. J. Pharmacol. Exp. Ther. 135 (1962) 312
11. Sadée W., Dagcioglu M., and Riegelman S. J. Pharm. Sci. 61 (1972) 1126
12. Krause W., Karras J., and Jakobs U. J. Chromatogr. 277 (1983) 191
13. Overdiek J.W., Hermens W.A., and Merkus F.W. J. Chromatogr. 341 (1985) 279
14. De Croo F., Van den Bossche W., and De Moerloose P. J. Chromatogr. 354 (1986) 367
15. Sherry J.H., O'Donnell J.P., and Colby H.D. J. Chromatogr. 374 (1986) 183
16. Los L.E., Coddington A.B., Ramjit H.G., and Colby H.D. Drug Metab. Dispos. 21 (1993) 1086
17. Herráez-Hernández R., Soriano-Vega E., and Campíns-Falcó P. J. Chromatogr. B: Biomed. Appl. 658 (1994) 303
18. Jankowski A., Skorek-Jankowska A., and Lamparczyk H. J. Pharm. Biomed. Anal. 4 (1996) 1359
19. Kaukonen A.M., Vuorela P., Vuorela H., and Mannermaa J.P. J. Chromatogr. A 797 (1998) 271
20. Sanz-Nebot V., Toro I., Bergés R., Ventura R., Segura J., and Barbosa J. J. Mass Spectrom. 36 (2001) 652
21. Qin Y., Wang X.B., Wang C., Zhao M., Wu M.T., Xu Y.X., and Peng S.Q. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 794 (2003) 193
22. Amendolaa L., Colamonici C., Mazzarino M., and Botrè F. Anal. Chim. Acta 475 (2003) 125
23. Goebel C., Trout G.J., and Kazlauskas R. Anal. Chim. Acta 502 (2004) 65
24. Sandall J.M., Millership J.S., Collier P.S., and McElnay J.C. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 839 (2006) 36
25. Dong H., Xu F., Zhang Z., Tian Y., and Chen Y. J. Mass Spectrom. 41 (2006) 477
26. Marchi I., Rudaz S., and Veuthey J.L. J. Pharm. Biomed. Anal. 49 (2009) 459
27. Guthrie R., and Susi A. Pediatrics 32 (1963) 338
28. Oliveira E.J., Watson D.G., and Morton N.S. J. Pharm. Biomed. Anal. 29 (2002) 803
29. la Marca G., Malvagia S., Filippi L., Fiorini P., Innocenti M., Luceri F., Pieraccini G., Moneti G., Francese S., Dani F.R., and Guerrini R. J. Pharm. Biomed. Anal. 48 (2008) 1392
30. Ter Heine R., Hillebrand M.J., Rosing H., van Gorp E.C., Mulder J.W., Beijnen J.H., and Huitema A.D. J. Pharm. Biomed. Anal. 49 (2009) 451
31. Mauriala T., Chauret N., Oballa R., Nicoll-Griffith D.A., and Bateman K.P. Rapid Commun. Mass Spectrom. 19 (2005) 1984
32. Edelbroek P.M., Heijden J.V., and Stolk L.M. Ther. Drug Monit. 31 (2009) 327
33. McDade T.W., Williams S., and Snodgrass J.J. Demography 44 (2007) 899
34. ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Methodology, ICH Topic Q2B (CPMP/ICH/281/95), The European Agency for the Evaluation of Medicinal Products, 1996.
35. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 70 (1998) 882
36. Chambers E., Wagrowski-Diehl D.M., Lu Z., and Mazzeo J.R. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 852 (2007) 22
37. Little J.L., Wempe M.F., and Buchanan C.M. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 833 (2006) 219
38. Bakhtiar R., and Majumdar T.K. J. Pharmacol. Toxicol. Methods 55 (2007) 262
39. Annesley T.M. Clin. Chem. 49 (2003) 1041
40. US Department of Health and Humans Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation, 2001.